Nika Pharmaceuticals, Inc. (NIKA)

Market Cap	708.22M
Revenue (ttm)	n/a
Net Income (ttm)	-62.78K
Shares Out	1.03B
EPS (ttm)	-0.00
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	100
Average Volume	681
Open	0.6900
Previous Close	0.6900
Day's Range	0.6900 - 0.6900
52-Week Range	0.1430 - 1.0000
Beta	n/a
RSI	36.30
Earnings Date	May 19, 2025

About Nika Pharmaceuticals

Nika Pharmaceuticals, Inc., a pharmaceutical company, develops drugs for the treatment of HIV/AIDS, hepatitis B and C, rheumatoid arthritis, cancer, diabetes, and various other diseases. It offers dietary supplements and antiviral drugs, as well as thymus nuclear glycoprotein for the treatment of HIV. The company was formerly known as Centennial Growth Equities Inc. and changed its name to Nika Pharmaceuticals, Inc. in May 2022. Nika Pharmaceuticals, Inc. was incorporated in 2000 and is based in Henderson, Nevada.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2000
• Country: United States
• Stock Exchange: OTCMKTS
• Ticker Symbol: NIKA